Low Powered Colorectal Anastomosis After Rectal Excision (OASIS)
OASIS
1 other identifier
observational
400
6 countries
15
Brief Summary
The objectiive of this prospective, international cohort is to compare two anastomotic techniques (DS vs TTSS) by collecting data during the surgery, and postoperatively (morbidity and functional outcomes). The choice of technique is left to the discretion of the surgeon based on her/his practices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Longer than P75 for all trials
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2025
CompletedFirst Posted
Study publicly available on registry
August 28, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2029
August 28, 2025
July 1, 2025
4 years
July 31, 2025
August 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To assess and compare the rate of anastomotic leakage at 1 month after rectal excision between double and single-stapling low colorectal anastomosis using advanced powered stapler
Proportion of anastomotic leakage (clinical and radiological) at 1 month after rectal surgery between double- and single-stapling low colorectal anastomosis using advanced powered stapler.
From the surgery to one month
Secondary Outcomes (11)
Overall morbidity and mortality rates at 1 month
At 1 month after the end of the surgery
The rate of anastomotic leakage at 6 and 12 months after rectal surgery;
At 12 month after the end of the surgery
Quality of life with QLQ C30 questionnaire
At 1, 6 and 12 months after rectal surgery
Quality of life with QLQ CR29 questionnaire
At 1,6 and 12 months after rectal surgery
Qualiy of life with EQ5D-5L
At 1, 6 and 12 months after rectal surgery
- +6 more secondary outcomes
Study Arms (1)
Rectal surgery with powered mechanical anastomosis performed with DS or TTSS techniques
This is an international cohort (France and other international centers) which consists of including patients undergoing rectal surgery with powered mechanical anastomosis performed with DS or TTSS techniques. Surgeons at each center perform one or both techniques. When both types of stapling are possible, the choice of technique is made by the surgeon during the preoperative consultation, in the best interest of the patients, after a case-by-case assessment.
Eligibility Criteria
In this exploratory, observational, prospective, IDEAL stage 2b International cohort study, we aim to include 400 patients with resection rectal and low powered colorectal anastomosis. This study is to compare two anastomotic techniques (DS vs TTSS) by collecting data during the surgery, and postoperatively (morbidity and functional outcomes). Surgeons at each center perform one or both techniques. When both types of stapling are possible, the choice of technique is made by the surgeon during the preoperative consultation, in the best interest of the patients, after a case-by-case assessment.
You may qualify if:
- Age ≥ 18
- Patients with rectal cancer lower than 12 cm from the anal verge requiring either a stapling anastomosis below 7 cm from the anal verge,
- Patients with powered mechanical anastomosis (INTOCARE devices)
- Patients with no metastasis
- Patients operated on by mini-invasive rectal excision (laparoscopic, robotic or TaTME);
- Patients with or without defunctioning ileostomy;
- Patients with or without neoadjuvant treatment;
- Patient who benefits by medicare system;
- Signed and dated informed consent
You may not qualify if:
- Patients with handsewn anastomosis
- Patients with perforated rectal cancer or preoperative pelvic sepsis ;
- Patients with inflammatory bowel disease;
- Patients operated on in emergency ;
- Patients with extended-TME or pelvic exenteration;
- Pregnancy or breast feeding period
- Legal incapacity or physical, psychological social or geographical status interfering with the patient's ability to agree to participate in the study
- Persons deprived of liberty or under guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (15)
Hôpital Universitaire de Belgique
Leuven, Belgium
Hôpital Universitaire McGill
Montreal, Canada
CHU de Quebec
Québec, Canada
Hôpital Universitaire de Shanghai
Shanghai, China
CHU de Besançon
Besançon, 25030, France
Bordeaux Colorectal Institute
Bordeaux, 33 000, France
Hôpital Bicêtre APHP
Le Kremlin-Bicêtre, 94 270, France
CHU de Lyon
Lyon, 69 495, France
Gp Hospitalier Diaconesses Croix St Simon
Paris, 75 020, France
Hôpital Européen Georges Pompidou APHP
Paris, 75012, France
Hôpital Saint Antoine APHP
Paris, 75012, France
Hôpital Charles Nicolle
Rouen, 76 031, France
Policlinique Universitaire Gemelli
Roma, Italy
Hôpital General universitaire Madrid
Madrid, Spain
Hôpital Universitaire de Vigo
Vigo, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Hélène HMM MAILLOU-MARTINAUD, CRA
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2025
First Posted
August 28, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
September 1, 2029
Study Completion (Estimated)
September 1, 2029
Last Updated
August 28, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
There are no plans to share individual participant data(IPD) with other researchers.